National Research (NRCIA) At $30.70 Forms Top; NEULION COMMON SHARES DELAWARE (NEUL) Shorts Raised By 9.08%

NEULION INC COMMON SHARES DELAWARE (OTCMKTS:NEUL) had an increase of 9.08% in short interest. NEUL’s SI was 701,900 shares in March as released by FINRA. Its up 9.08% from 643,500 shares previously. With 41,500 avg volume, 17 days are for NEULION INC COMMON SHARES DELAWARE (OTCMKTS:NEUL)’s short sellers to cover NEUL’s short positions. The SI to NEULION INC COMMON SHARES DELAWARE’s float is 0.86%. The stock increased 4.71% or $0.0187 during the last trading session, reaching $0.4158. About 1,900 shares traded. NeuLion, Inc. (OTCMKTS:NEUL) has 0.00% since March 8, 2017 and is . It has underperformed by 16.70% the S&P500.

National Research Corporation (NRCIA) formed multiple top with $31.93 target or 4.00% above today’s $30.70 share price. National Research Corporation (NRCIA) has $819.68 million valuation. The stock decreased 1.29% or $0.4 during the last trading session, reaching $30.7. About 21,646 shares traded. National Research Corporation (NASDAQ:NRCIA) has 0.00% since March 8, 2017 and is . It has underperformed by 16.70% the S&P500.

NeuLion, Inc. provides enterprise digital video solutions in the United States and internationally. The company has market cap of $117.29 million. The Company’s flagship solution, the NeuLion Digital Platform, is a proprietary cloud turnkey solution that enables the delivery and monetization of digital video content. It currently has negative earnings. The NeuLion Digital Platform provides content owners and rights holders with an end-to-end turnkey video distribution platform that enables them to ingest, encode, manage, deliver, monetize, and analyze the performance of their live and on-demand digital video content.

Since January 25, 2018, it had 1 insider purchase, and 2 insider sales for $58.04 million activity. Another trade for 5.26M shares valued at $101.60 million was made by Hays Michael D. on Thursday, February 15. The insider Amandla MK Trust bought $106.10M.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: